Fidelity Investments
MIST icon

Fidelity Investments’s Milestone Pharmaceuticals MIST Stock Holding History

Fidelity Investments’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-239,600
Closed -$3.84M – 4028
2019
Q4 		$3.84M Hold
239,600
– – ﹤0.01% 2116
2019
Q3 		$4.14M Hold
239,600
– – ﹤0.01% 2100
2019
Q2 		$6.5M Buy
+239,600
New +$4.94M ﹤0.01% 2017

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments's MIST Position: Q1 2020 in Review

Fidelity Investments sold out of Milestone Pharmaceuticals (MIST) in Q1 2020, closing a stake of 239,600 shares — an estimated $3.84M sold.

Fidelity Investments first reported a position in MIST in Q2 2019 and held it in 3 quarters. The position peaked at $6.5M in Q2 2019. 19 funds tracked by Wall St. Rank hold MIST as of Q1 2020.

  • Fidelity Investments reported no remaining Milestone Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Fidelity Investments sold 239,600 Milestone Pharmaceuticals shares in Q1 2020, an estimated $3.84M.
  • Fidelity Investments first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Fidelity Investments's Milestone Pharmaceuticals position peaked at $6.5M in Q2 2019.
  • 19 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2020.

Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.